Boehringer Ingelheim
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one.
Beyond's analysis on Boehringer Ingelheim
- — Boehringer Ingelheim commits $5 million over three years to a WHO Foundation partnership targeting obesity and metabolic health gaps
- — Boehringer Ingelheim earns Human‑Animal Bond Certification, boosting its animal‑health brand credibility
Recent news mentioning Boehringer Ingelheim
- — Boehringer Ingelheim und die WHO Foundation starten eine weltweite Zusammenarbeit, um die Versorgungslücke im Bereich Adipositas und Stoffwechselgesundheit zu schließen
- — Boehringer Ingelheim et la Fondation de l'OMS lancent une collaboration mondiale pour combler les lacunes en matière d'obésité et de santé métabolique
- — Boehringer Ingelheim y la Fundación de la OMS lanzan una colaboración mundial en obesidad y salud metabólica
- — Variant Bio Expands Target Discovery Collaboration with Boehringer Ingelheim into Cardiovascular Disease
- — Zukunftsgestalter: Traditionskonzern statt Big Pharma – wie Boehringer Ingelheim der Konkurrenz die Talente wegschnappt
- — Zukunftsgestalter: Traditionskonzern statt Big Pharma – wie Boehringer Ingelheim der Konkurrenz die Talente wegschnappt
- — Boehringer Ingelheim Celebrates Grand Opening of New U.S. Animal Health Headquarters in Johns Creek, Georgia